Boultwood et al., "Allelic Loss of IRF1 in Myelodysplasia and Acute Myeloid Leukemia: Retention of IRF1 on the 5q-Chromosome in Some Patients With the 5q- Syndrome," Blood 82(9):2611-2616 (1993). |
Carter et al., "Genetic Lesions in Preleukemia," Critical Rev. Oncogenesis 3(4):339-364 (1992). |
Cha et al., "Human Interferon Regulatory Factor 1: Intron-Exon Organization," DNA and Cell Biol. 11(8):605-611 (1992). |
Chomczynski, P. and Sacchi, N., "Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction," Analytical Biochem. 162:156-159 (1987). |
Foley et al., "Quantitation of RNA using the polymerase chain reaction," TIG 9(11):380-385 (1993). |
Harada et al., "Absence of the Type I IFN System in EC Cells: Transcriptional Activator (IRF-1) and Repressor (IRF-2) Genes Are Developmentally Regulated," Cell 63:303-312 (1990). |
Harada et al., "Anti-Oncogenic and Oncogenic Potentials of Interferon Regulatory Factors-1 and -2," Science 259:971-974 (1993). |
Harada et al., "Structurally Similar but Functionally Distinct Factors, IRF-1 and IRF-2, Bind to the Same Regulatory Elements of IFN and IFN-Inducible Genes," Cell 58:729-739 (1989). |
Harada et al., "Structure and Regulation of the Human Interferon Regulatory Factor-1 (IRF-1) and IRF-2 Genes: Implications for a Gene Network in the Interferon System," Mol. Cell. Biol. 14(2):1500-1509 (1994). |
Itoh et al., "Assignment of the Human Interferon Regulatory Factor-1 (IRF-1) Gene to Chromosome 5q23-q31," Genomics 10:1097-1099 (1991). |
Itoh et al., "Sequence of a cDNA coding for human IRF-2," Nucl. Acids Res. 17(20):8372 (1989). |
Kerim et al., "5q- Anomaly in Lymphoid Disorders," Leukemia 4(1):12-15 (1990). |
Kirchhoff et al., "Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes," Nucl. Acids Res. 21(12):2881-2889 (1993). |
Le Beau et al., "Clinical and Cytogenetic Correlations in 63 Patients With Therapy-Related Myelodysplastic Syndromes and Acute Nonlymphocytic Leukemia: Further Evidence for Characteristic Abnormalities of Chromosomes No. 5 and 7," J. Clin. Oncol. 4(3):325-345 (1986). |
Le Beau et al., "Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases," PNAS USA 90:5484-5488 (1993). |
Lengyel, P., "Tumor-suppressor genes: News about the interferon connection," PNAS USA 90:5893-5895 (1993). |
Levine et al., "The Tumor Suppressor Genes," Annu. Rev. Biochem. 62:623-651 (1993). |
Lewin, B., "Oncogenic Conversion by Regulatory Changes in Transcription Factors," Cell 64:303-312 (1991). |
Makino et al., "Evaluation of Quantitative Detection of mRNA by the Reverse Transcription-Polymerase Chain Reaction," Technique 2(6):295-301 (1990). |
Maruyama et al., "Sequence of a cDNA coding for human IRF-1," Nucl. Acids Res. 17(8):3292 (1989). |
Matsuyama et al., "Targeted Disruption of IRF-1 or IRF-2 Results in Abnormal Type I IFN Gene Induction and Aberrent Lymphocyte Development," Cell 75:83-97 (1993). |
Miyamoto et al., "Regulated Expression of a Gene Encoding a Nuclear Factor, IRF-1, That Specifically Binds to IFN-.beta. Gene Regulatory Elements," Cell 54:903-913 (1988). |
Nimer, S.D. and Golde, D.W., "The 5q- Abnormality," Blood 70(6):1705-1712 (1987). |
Pedersen, B. and Jensen, I.M., "Clinical and Prognostic Implications of Chromosome 5q Deletions: 96 High Resolution Studied Patients," Leukemia 5(7):566-573 (1991). |
Pedersen-Bjergaard et al., "Chromosome Aberrations and Prognostic Factors in Therapy-Related Myelodysplasia and Acute Nonlymphocytic Leukemia," Blood 76(6):1083-1091 (1990). |
Ponte et al., "Evolutionary conversation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA," Nucl. Acids Res. 12(3):1687-1696 (1984). |
Sugimoto et al., "Mutations of the p53 Gene in Myelodysplastic Syndrome (MDS) and MDS-Derived Leukemia," Blood 81(11):3022-3026 (1993). |
Tanaka, N. and Taniguchi, T., "Cytokine Gene Regulation: Regulatory cis-Elements and DNA Binding Factors Involved in the Interferon System," Adv. Immunol. 52:263-281 (1992). |
Tanaka et al., "Age-related changes in the proportion of amyloid precursor protein mRNAs in Alzheimer's disease and other neurological disorders," Mol. Brain Res. 15:303-310 (1992). |
Tanaka et al., "Recognition DNA Sequences of Interferon Regulatory Factor-1 (IRF-1) and IRF-2, Regulators of Cell Growth and the Interferon System," Mol. Cell. Biol. 13(8):4531-4538 (1993). |
Van den Berghe et al., "the 5q- Anomaly," Cancer Genet. Cytogenet. 17:189-255 (1985). |
Wang et al., "Quantitation of mRNA by the polymerase chain reaction," PNAS USA 86:9717-9721 (1989). |
Willman et al., "Deletion of IRF-1, Mapping to Chromosome 5q31.1, in Human Leukemia and Preleukemic Myelodysplasia," Science 259:968-971 (1993). |
Yamada et al., "Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice," PNAS USA 88:532-536 (1991). |
Harada et al, (1994), "Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia leukemia; a possible mechanism of tumor suppression inactivation", Oncogene 9:3313-3320. |
Cha et al, (Feb. 18, 1994), "Human interferon regulatory factor 2 gene", J. Biol. Chem. 269(7):5279-5287. |